Indian Journal of Respiratory Care

IJRC Email      Register      Login

VOLUME 12 , ISSUE 1 ( January-March, 2023 ) > List of Articles

Original Article

Computed Tomography Thorax Patterns in the Patients of Chronic Kidney Disease with Microbiologically Confirmed Coronavirus Disease-2019: An Experience from a Tertiary Care Hospital

K Anirudha, BL Shashi Bhushan, KU Vivek, AS Deepa

Keywords : Computed tomography, coronavirus, coronavirus disease-2019, ground-glass opacities

Citation Information : Anirudha K, Bhushan BS, Vivek K, Deepa A. Computed Tomography Thorax Patterns in the Patients of Chronic Kidney Disease with Microbiologically Confirmed Coronavirus Disease-2019: An Experience from a Tertiary Care Hospital. Indian J Respir Care 2023; 12 (1):12-16.

DOI: 10.5005/jp-journals-11010-1007

License: CC BY-NC-SA 4.0

Published Online: 14-03-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Introduction: A retrospective study aimed at analyzing the patterns in the CT scans of patients of CKD infected with COVID-19 in the period of two months. We reviewed the CT scans for the pattern of Lung involvement, number of lobe involved, distribution of the lesions and characteristic appearances, along with other coexisting features. Methodology: After consent, we studied the parameters of interest among the patients admitted in the dedicated COVID-19 hospital in Bengaluru, Karnataka, who were admitted during the months of October and November 2020. Each CT scan was reported by in-house radiologist and results were analyzed. Results: We found that of the 92 CKD patients, 51 had got a CT thorax done, out of which 45 had lung parenchymal involvement of COVID-19; of which 44 were bilateral. 26 of the patients had only peripheral lesions and 19 had both central and peripheral distribution. The most common finding was GGOs occurring in 43 of them while 30 of them had GGOs with consolidation. This study shows that the CT patterns in patients of CKD with COVID-19 involves mainly peripheral distribution of lesions with majority involving >2 lobes, with GGOs being most common finding; similar to those without CKD, but the incidence of pleural effusions and mediastinal lymphadenopathy is slightly higher, possibly because of coexistent comorbidities contributing to the same. Conclusion: We conclude that though some patients with CKD and COVID-19 can have a normal lung, the involvement of lungs is more severe and extensive in distribution, implying a more severe involvement of the lung. Hence, further Studies are required on larger population to ascertain the findings and further resources should be allocated for the benefit of this significantly vulnerable patients in this era.

  1. Weekly Epidemiological Update – 24 November, 2020. Available from: update--24-november-2020. [Last accessed on 2020 Nov 30].
  2. MoHFW | Home. Available from: [Last accessed on 2020 Nov 30].
  3. Zhou J, Liao X, Cao J, et al. Differential diagnosis between the coronavirus disease 2019 and Streptococcus pneumoniae pneumonia by thin–slice CT features. Clin Imaging 2021;69:318–23.
  4. Han R, Huang L, Jiang H, et al. Early clinical and CT manifestations of coronavirus disease 2019(COVID–19) pneumonia. AJR Am J Roentgenol 2020;215:338–43.
  5. Chaganti S, Grenier P, Balachandran A, et al. Automated quantification of CT patterns associated with COVID–19 from chest CT. Radiol Artif Intell 2020;2:e200048.
  6. Guan W, Liu J, Yu C. CT findings of coronavirus disease (COVID–19) severe pneumonia. AJR Am J Roentgenol 2020;214:W2020;214.
  7. Fang Y, Zhang H, Xie J, et al. Sensitivity of chest CT for COVID–19: Comparison to RT–PCR. Radiology 2020;296:E115–7.
  8. Qi X, Lei J, Yu Q, et al. CT imaging of coronavirus disease 2019(COVID–19): From the qualitative to quantitative. Ann Transl Med 2020;8:256.
  9. Li J, Li SX, Zhao LF, et al. Management recommendations for patients with chronic kidney disease during the novel coronavirus disease 2019(COVID–19) epidemic. Chronic Dis Transl Med 2020;6:119–23.
  10. Benedetti C, Waldman M, Zaza G, et al. COVID–19 and the kidneys: An update. Front Med (Lausanne) 2020;7:423.
  11. Ng JH, Bijol V, Sparks MA, et al. Pathophysiology and pathology of acute kidney injury in patients with COVID–19. Adv Chronic Kidney Dis 2020;27:365–76.
  12. Naicker S, Yang CW, Hwang SJ, et al. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int 2020;97:824–8.
  13. Guan CS, Lv ZB, Yan S, et al. Imaging features of coronavirus disease 2019(COVID–19): Evaluation on thin–section CT. Acad Radiol 2020;27:609–13.
  14. Valeri AM, Robbins–Juarez SY, Stevens JS, et al. Presentation and outcomes of patients with ESKD and COVID–19. J Am Soc Nephrol 2020;31:1409–15.
  15. Tang B, Li S, Xiong Y, et al. COVID–19 pneumonia in a hemodialysis patient. Kidney Med 2020;2:354–8.
  16. Wang R, Liao C, He H, et al. COVID–19 in hemodialysis patients: A report of 5 cases. Am J Kidney Dis 2020;76:141–3.
  17. Alalwan AA, Taher A, Alaradi AH. A Hemodialysis patient with severe COVID–19 pneumonia. Cureus 2020;12:e7995.
  18. Chowdhury MR, Akter KS, Alam MZ, et al. COVID–19 disease complicated with severe pneumonia in a patient with end stage renal disease (ESRD): A case report from Bangladesh. Adv Infect Dis 2020;10:101–9.
  19. Du X, Li H, Dong L, et al. Clinical features of hemodialysis patients with COVID–19: A single–center retrospective study on 32 patients. Clin Exp Nephrol 2020;24:829–35.
  20. Lano G, Braconnier A, Bataille S, et al. Risk factors for severity of COVID–19 in chronic dialysis patients from a multicentre French cohort. Clin Kidney J 2020;13:878–88.
  21. Channappanavar R, Fett C, Mack M, et al. Sex–based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol 2017;198:4046–53.
  22. Mehta P, McAuley DF, Brown M, et al. COVID–19: Consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–4.
  23. Vaziri ND, Pahl MV, Crum A, et al. Effect of uremia on structure and function of immune system. J Ren Nutr 2012;22:149–56.
  24. Zou X, Chen K, Zou J, et al. Single–cell RNA–seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019–nCoV infection. Front Med 2020;14:185–92.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.